Company intelligence / Profile preview

Hayat Pharmaceutical Industries Co. PLC

Amman, Jordan

Ownership: Private
Development stage: Commercial

Overview

Hayat Pharmaceutical Industries Co. PLC manufactures and markets over 100 branded generic pharmaceuticals with a strong presence across 12 MENA countries. The company continues to expand its product pipeline and manufacturing capabilities, recently launching new products such as Biodal® Drops for children. It maintains cGMP-compliant facilities and invests in modern production lines to support future growth

Therapeutic areas: OtherEndocrinologyRheumatology
Modalities: Branded generics (primarily small molecules)some focus on novel dosage forms and delivery technologies
Industry: Biotech

Drug pipeline

1 asset

cholecalciferol

Commercial

Indications: Vitamin D deficiency

Beyond the preview

Go deeper on Hayat Pharmaceutical Industries Co. PLC.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hayat Pharmaceutical Industries Co. PLC.

Explore the full profile